The Harvard Drug Group LLC recalls Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Ma…
- Recall date
- February 17, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0383-2026
- FDA classification
- Class II
- Brand / firm
- The Harvard Drug Group LLC
- Sold / distributed
- Nationwide US.
Why it was recalled
Defective container; inadequately sealed blister packaging.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
Get recall alerts
Free email alert whenever The Harvard Drug Group LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: The Harvard Drug Group LLC